Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations

NCT03764722 is registered in ClinicalTrials.gov with Collegium Medicum w Bydgoszczy as lead sponsor.

NCT NCT03764722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03764722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations
Lead sponsor
Collegium Medicum w Bydgoszczy
Phase
Phase 4
Overall status
Unknown status
Start date
August 1, 2018
Completion date
December 31, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systolic heart failure